MSSGX
Price
$17.03
Change
+$0.47 (+2.84%)
Updated
Dec 3 closing price
Net Assets
339.61M
VEXRX
Price
$115.63
Change
+$1.21 (+1.06%)
Updated
Dec 3 closing price
Net Assets
20.54B
Interact to see
Advertisement

MSSGX vs VEXRX

Header iconMSSGX vs VEXRX Comparison
Open Charts MSSGX vs VEXRXBanner chart's image
Morgan Stanley Inst Inception I
Price$17.03
Change+$0.47 (+2.84%)
VolumeN/A
Net Assets339.61M
Vanguard Explorer Adm
Price$115.63
Change+$1.21 (+1.06%)
VolumeN/A
Net Assets20.54B
MSSGX vs VEXRX Comparison Chart in %
View a ticker or compare two or three
VS
MSSGX vs. VEXRX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSSGX is a Buy and VEXRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 20.5B vs. MSSGX (340M). MSSGX pays higher dividends than VEXRX: MSSGX (0.92) vs VEXRX (0.48). MSSGX was incepted earlier than VEXRX: MSSGX (36 years) vs VEXRX (24 years). MSSGX (1.13) is less costly to investors than VEXRX (0.33). MSSGX is a more actively managed with annual turnover of: 100.00 vs. VEXRX (35.00). VEXRX has a lower initial minimum investment than MSSGX: VEXRX (50000) vs MSSGX (1000000). MSSGX annual gain was more profitable for investors over the last year : 0.33 vs. VEXRX (-6.40). VEXRX return over 5 years is better than : -3.51 vs. MSSGX (-29.42).
MSSGXVEXRXMSSGX / VEXRX
Total Expense Ratio1.000.33303%
Annual Report Gross Expense Ratio1.130.33342%
Fund Existence36 years24 years-
Gain YTD3.2817.17846%
Front LoadN/AN/A-
Min. Initial Investment1000000500002,000%
Min. Initial Investment IRAN/AN/A-
Net Assets340M20.5B2%
Annual Yield % from dividends0.920.48192%
Returns for 1 year0.33-6.40-5%
Returns for 3 years85.1418.59458%
Returns for 5 years-29.42-3.51839%
Returns for 10 years7.2334.8621%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ISCIX52.11N/A
N/A
Federated Hermes Intl Small-Mid Co IS
HLHIX30.90N/A
N/A
Virtus KAR Health Sciences Inst
CHTCX19.80N/A
N/A
Invesco Charter C
TBCIX221.69N/A
N/A
T. Rowe Price Blue Chip Growth I
GMOWX21.86N/A
N/A
GMO Resources VI